default author photo

Xue-Zhong Yu

Medical University of South Carolina - Hollings Cancer Center

Medical University of South Carolina - Department of Microbiology and Immunology

United States

SCHOLARLY PAPERS

2

DOWNLOADS

110

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Targeting Cancer Mitochondria by Lipid-Selenium Conjugate Drug Results in Malate/Fumarate Exhaustion and Inducesmitophagy-Mediated Tumor Suppression

Number of pages: 67 Posted: 14 Mar 2023
Medical University of South Carolina - Department of Biochemistry and Molecular Biology, Medical University of South Carolina - Department of Biochemistry and Molecular Biology, Medical University of South Carolina - Department of Biochemistry and Molecular Biology, Medical University of South Carolina - Department of Biochemistry and Molecular Biology, Medical University of South Carolina - Department of Biochemistry and Molecular Biology, Medical University of South Carolina - Department of Biochemistry and Molecular Biology, Medical University of South Carolina - Department of Biochemistry and Molecular Biology, Medical University of South Carolina - Department of Biochemistry and Molecular Biology, Medical University of South Carolina - Department of Biochemistry and Molecular Biology, Medical University of South Carolina - Hollings Cancer Center, Medical University of South Carolina - Hollings Cancer Center, Yeditepe University - Department of Genetics and Bioengineering, Medical University of South Carolina - Hollings Cancer Center, Medical University of South Carolina - Hollings Cancer Center, Medical University of South Carolina - Department of Biochemistry and Molecular Biology, Medical University of South Carolina - Hollings Cancer Center, Medical University of South Carolina - Hollings Cancer Center and Medical University of South Carolina - Department of Biochemistry and Molecular Biology
Downloads 58 (980,173)

Abstract:

Loading...

Ceramide, CerS1, Fumarate, Drp1, Metabolism, Mitophagy, TCA cycle

2.

RNA-Binding Protein PCBP1/hnRNP E1 is an Intracellular Checkpoint for Shaping Effector Versus Regulatory T Cells in Immunity and Cancer

Number of pages: 58 Posted: 12 Jul 2019
Medical University of South Carolina - Department of Microbiology and Immunology, Medical University of South Carolina - Department of Microbiology and Immunology, Medical University of South Carolina - Department of Microbiology and Immunology, Medical University of South Carolina - Department of Microbiology and Immunology, Medical University of South Carolina - Department of Microbiology and Immunology, Medical University of South Carolina - Department of Microbiology and Immunology, Medical University of South Carolina - Department of Public Health Sciences, Medical University of South Carolina - Department of Public Health Sciences, Medical University of South Carolina - Department of Microbiology and Immunology, Medical University of South Carolina - Department of Microbiology and Immunology, Medical University of South Carolina - Hollings Cancer Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Medical University of South Carolina and Ohio State University (OSU) - Department of Internal Medicine
Downloads 52 (1,041,696)

Abstract:

Loading...

RNA-binding protein, PCBP1, effector T cells, regulatory T cells, Intracellular Checkpoint, Cancer Immunotherapy, Predictor-of-Response, immune-suppression